ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 59 filers reported holding ADICET BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20 | +1900.0% | 14,946 | +1930.7% | 0.00% | – |
Q2 2023 | $1 | -93.8% | 736 | -74.7% | 0.00% | – |
Q1 2023 | $16 | -100.0% | 2,911 | -81.2% | 0.00% | – |
Q3 2022 | $219,000 | +812.5% | 15,454 | +1162.6% | 0.00% | – |
Q1 2022 | $24,000 | -91.9% | 1,224 | -92.8% | 0.00% | – |
Q4 2021 | $295,000 | +2581.8% | 16,895 | +1307.9% | 0.00% | – |
Q3 2021 | $11,000 | -8.3% | 1,200 | 0.0% | 0.00% | – |
Q2 2021 | $12,000 | – | 1,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |